Patanjali, a massive corporate entity, has been utilizing political support and regulatory loopholes to promote pseudoscientific products, leading to a public health emergency. Their false claims about curing various diseases, including cancer, have misled people, resulting in delayed or discontinued scientifically proven treatments. The media, law enforcement, and drug regulators have failed to hold Patanjali accountable, allowing the spread of misinformation. This case highlights the importance of strengthening drug regulations, promoting health security, and recognizing health as a political issue.